News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Five papers suggested by Arndt Vogel
Dec 24, 2024, 12:16

Five papers suggested by Arndt Vogel

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.

ESMO

He suggested following few must-read papers on X:

1. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Authors:  Rachna T. Shroff et al.

Five papers suggested by Arndt Vogel

Five papers suggested by Arndt Vogel

3. Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial

Authors: Laura A. Dawson et al.

Five papers suggested by Arndt Vogel

4. A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma

Authors: L. Goyal et al.

Five papers suggested by Arndt Vogel

5. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals

Authors: Amanda L. Blackford et al.

Five papers suggested by Arndt Vogel

More Posts Featuring Arndt Vogel.

Amanda L. Blackford Arndt Vogel Biliary tract cancer cancer cholangiocarcinoma Daniel Q. Huang ESMO Clinical Practice Guideline Hannover Medical School hepatocellular carcinoma Laura A Dawson Luan C.V. Lima Lubna Al-Sharif Matheus Souza OncoDaily Oncology Pancreatic Cancer Rachna T. Shroff
Special Coverage
Science
Dec 24, 2024, 12:16
Five papers suggested by Arndt Vogel
Blog
Dec 24, 2024, 12:09
Personalized Cancer Therapy: The Role of Individualized Neoantigen Therapy
Science
Dec 24, 2024, 11:44
Erman Akkus: Pancreatic Cancer - Year in review
Blog
Dec 24, 2024, 11:40
Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy
Blog
Dec 24, 2024, 11:36
How T-cells recognize foreign proteins has changed the way we think about the immune response
Blog
Dec 24, 2024, 11:33
Muhammad Umair Mushtaq: Utilizing CAR-T therapy in relapsed/refractory multiple myeloma
Science
Dec 24, 2024, 11:31
Breakthrough of solid tumor treatment: CAR-NK immunotherapy, review by Hung Trinh
Insight
Dec 24, 2024, 11:28
Jack Huang: Strategies of Combination Immunotherapies in Cancer
Science
Dec 24, 2024, 11:24
Long term natural history of Branch Duct Intraductal Papillary Mucinous Neoplasm beyond 10 years of follow-up
Science
Dec 24, 2024, 11:20
Impact of Financial Toxicity on Treatment Adherence and QOL in Pancreatic Cancer
Blog
Dec 24, 2024, 11:09
Erman Akkus: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma
Blog
Dec 24, 2024, 08:18
Jasmine Kamboj: Call for Interactive Research Corise by ASCO and AIOM